Article
J. Agric. Food Chem., Vol. 58, No. 4, 2010 2175
flame ionization detector (FID) and coupled to a quadrupole Agilent 5973
network mass selective detector working in electron impact (EI) mode at
70 eV (scanning over the 35-350 amu range). The gas chromatograph was
equipped with two fused silica capillary columns HP-1 (PDMS, 50 m ꢀ
0.2 mm i.d., film thickness = 0.33 μm). The analytical parameters
(identical for GC and GC-MS analyses unless specified) were the follow-
ing: The carrier gas was helium at a flow rate of 1 mL/min. The oven
temperature was programmed from 60 to 250 at 2 °C/min and held
isothermal for 40 min. The injector (split mode, ratio 1/100) temperature
was 250 °C. The FID temperature was set at 250 °C, and in the GC-MS
analyses, the temperatures of the ion source and transfer line were 170 and
280 °C, respectively. Retention indices (RI) were determined from the
retention times of a series of n-alkanes with linear interpolation. Quanti-
tative data were obtained from FID area percentages without the use of
correction factors. The constituents of the essential oil were identified by
comparison of their mass spectral pattern and RI with those of pure
compounds registered in commercial libraries and literature data and with
a laboratory-made database built from authentic compounds. The identi-
fication of isochavicol esters 2-4 was carried out by co-injection of the
essential oil with ester mixtures synthesized from pure isochavicol (vide
infra).
[dd, 3H, J = 1.3, 6.3 Hz; H7], 2.79 [hept, 1H, J = 7.0 Hz; (CH3)2CH], 6.18
[dq, 1H, J = 6.3, 15.7 Hz; H6], 6.39 [br d, 1H, J = 15.7 Hz; H5], 6.99 [d,
2H, J = 8.6 Hz; H2], 7.32 [d, 2H, J = 8.6 Hz; H3]; 13C NMR δ 175.54,
149.54, 135.49, 130.04, 126.56, 125.72, 121.38, 34.08, 18.84, 18.20; EI-MS
m/z (%) 41 (5), 43 (27), 71 (5), 77 (8), 105 (5), 107 (5), 133 (38), 134 (100),
135 (10), 204 (5).
1
4-(Prop-(1E)-enyl)phenyl Propionate (3) (67%). H NMR (Figure S4
of the Supporting Information) δ 1.26 [t, 3H, J = 7.5 Hz; CH3CH2], 1.87
[dd, 3H, J = 1.3, 6.3 Hz; CH3CH2], 2.58 [q, 2H, J = 7.5 Hz; CH2CO], 6.18
[dq, 1H, J = 6.3, 15.7 Hz; H6], 6.38 [br d, 1H, J = 15.7 Hz; H5], 7.00 [d,
2H, J = 8.6 Hz; H2], 7.32 [d, 2H, J = 8.6 Hz; H3]; 13C NMR (Figure S5 of
the Supporting Information) δ 173.00, 149.40, 135.59, 130.00, 126.63,
125.88, 121.48, 27.73, 18.49, 9.08; EI-MS m/z (%) 57 (10), 77 (8), 105 (6),
107 (7), 115 (4), 117 (5), 133 (51), 134 (100), 135 (10), 190 (6) (Figure S7 of
the Supporting Information).
Bacterial Strains and Culture Conditions. References strains of
Escherichia coli (ATCC 9739), Staphylococcus aureus subsp. aureus
(ATCC 6538), Nocardia asteroides (ATCC 19247), Klebsiella pneumoniae
(IBMC Strasbourg), Staphylococcus hemolyticus (IBMC Strasbourg),
Salmonella enterica subsp. enterica, Serovar Enteritidis (Institut de Biolo-
ꢀ
gie Moleculaire et Cellulaire, Strasbourg), Mycobacterium bovis BCG
NMR. The NMR spectra were recorded on a Bruker WM 200 MHz
spectrometer in CDCl3. The chemical shift values are reported with
reference to tetramethylsilane, and the coupling constants are given in hertz.
Essential Oil Fractionation. The essential oil was submitted to flash
chromatography on 40-63 μm silica gel, using petroleum ether with
increasing amounts of diethyl ether as eluent. The fractions were analyzed
by GC-MS, and those containing the isochavicol esters were gathered for
the preparation of isochavicol.
Synthesis of Reference Compounds. Isochavicol (1). D. crinitus
essential oil fraction rich in isochavicol esters (prepared as described
above) (1.01 g) was diluted in 6 mL of anhydrous diethyl ether and added
dropwise to a stirred suspension of 362 mg of lithium aluminum hydride
(LAH) in diethyl ether (15 mL). The mixture was stirred at room
temperature for 24 h, then cooled to 0 °C, and quenched by the sequential
addition of water and diluted hydrochloric acid until acidic pH. The
mixture was then decanted and the aqueous layer extracted twice with
diethyl ether. The combined organic phases were washed with brine, dried
on magnesium sulfate, and evaporated to give 907 mg of a slightly yellow
oil, which was purified by flash chromatography on silica gel using
petroleum ether/diethyl ether 4:1 as eluent, to give finally 324 mg of
4-(prop-(1E)-enyl)phenol (isochavicol 1) as white crystals: 1H NMR δ 1.85
[dd, 3H, J = 1.5, 6.4 Hz; H7], 4.68 [s, 1H, OH], 6.08 [dq, 1H, J = 6.4,
15.7 Hz; H6], 6.33 [br d, 1H, J = 15.7 Hz; H5], 6.76 [d, 1H, J = 8.7 Hz;
H2], 7.21 [d, 1H, J = 8.7 Hz; H3]; 13C NMR δ 154.38, 130.86, 130.24,
127.02, 123.42, 115.38, 18.69; EI-MS m/z (%) 77 (22), 91 (14), 103 (9), 105
(28), 107 (29), 115 (12), 117 (9), 119 (10), 133 (78), 134 (100).
(Pasteur), and E. coli, PQ37 (F- thr leu his-4 pyrD thi galE galK lacΔU169
srl300::Tn10 rpoB rpsL uvrA rfa trp::Mucþ sfiA::Mud (Ap, lac) cts), were
obtained from the Collection of the Institute Pasteur, Paris, France. The
essential oil was screened as toxic against Plasmodium falciparum FcB1,
ꢀ
which was from the Museum National d’Histoire Naturelle. Bacteria
species were cultivated for 24 h in Mueller Hinton’s medium (MH) at 37 °C
except N. asteroides ATCC 19247, which was cultivated in heart-brain
infusion (HBI) at 30 °C for 48 h, at 30 °C in malt extract agar for
Aspergillus niger, and in Sabouraud dextrose medium (Sanofi Diagnostic
Pasteur) for Candida albicans.
Disk Diffusion Assay. The antibacterial activity of the essential oil
was evaluated using the agar diffusion test according to the Kirby-Bauer
method (24) with small adaptations. Briefly, culture suspension of the
tested microorganisms (approximately 106 CFU/mL) was spread on the
solid medium plates (40 mL). Five microliters of serial dilutions in
dimethyl sulfoxide (DMSO) (1/2, 1/5, and 1/10 v/v) of the essential oil
were placed onto the solid media plates. The diameter of inhibition was
measured after 24 or 48 h of incubation at 30 or 37 °C. Ampicillin,
itraconazole, and DMSO were used as positive and negative controls,
respectively.
Minimum Inhibitory Concentration (MIC) Determinations for
Mycobacteria. MICs were determined using the new microdilution
resazurin assay (MRA) (25). Resazurin salt powder (Sigma) was prepared
at 0.01% (w/v) in distilled water, sterilized by filtration through a 0.22 μm
membrane, and stored at 4 °C for a week. Drug stock solutions were
prepared in DMSO at a concentration of 20 mg/mL and frozen until used.
The inocula were prepared from M. bovis BCG strains grown in 7H9
medium supplemented with 10% albumin, dextrose, catalase (ADC)
enrichment. Two microliters of 2-fold serial dilutions of each drug was
prepared in 200 μL of 7H9 medium directly in 96-well plates at concentra-
tions from 100 to 0.1 μg/mL. Growth controls containing DMSO and
isoniazid (from 1 μg/mL to 1 ng/mL) were also included. The plates were
covered, sealed, and incubated at 37 °C. After 8 days, 30 μL of resazurin
solution was added to each well and plates were allowed to incubate at
37 °C for an additional 24 h. A change from blue to pink indicates
reduction of resazurin and therefore bacterial growth. The MIC was
defined as the lowest drug concentration that prevented this color change.
Cytotoxicity Evaluation. VERO cell lines were maintained in
Dulbecco modified Eagle medium (DMEM) supplemented with 5% fetal
calf serum (FCS), at 37 °C in air with 5% CO2. Proliferating cells were
seeded in 96-well microtitration plates at a density of 105 cells/mL, which
were further incubated for 24 h at 37 °C under 5% CO2 in air before each
assay. Various concentrations of solutions of compounds in 1% DMSO
were added and then incubated for 48 h as described above. At the end of
this, 20 μL of dimethylthiazolyldiphenyl tetrazolium bromide solution
(MTT, Sigma) (5 mg/mL) was added to each well and further incubated
for 4 h at 37 °C to allow the formation of formazan. The crystals of
formazan were then dissolved with 100 μL of a freshly prepared solution of
sodium dodecyl sulfate (SDS) 10% (15 mL) and 1 N HCl (150 μL). The
optical density of each well was measured at 595 nm using a multiwell plate
Isochavicol Esters. The typical procedure was performed as follows: To
1 equiv of 1 diluted in dichloromethane (DCM) (ca. 4 mL/100 mg 1) were
added sequentially under stirring 1.2 equiv of triethylamine and 1.3 equiv
of acyl chloride (either as a single compound or in mixture). The solution
was stirred for 24-72 h and then poured into water. After decantation, the
aqueous phase was extracted twice with DCM, and the combined organic
phases were washed with brine, dried on magnesium sulfate, and evapo-
rated to give an oily product, which was purified by flash chromatography
on silica gel using petroleum ether/diethyl ether for elution. In the case of
the preparation of the ester mixtures, a simple filtration on silica gel using
such a type of eluent was sufficient. The pure or mixed esters were finally
obtained as colorless oils.
Ester Mixture 1. The use of a mixture of acetyl, n-butyryl, n-valeryl and
n-hexanoyl chlorides as acylating agents (respective massic percentages:
20, 25, 27, and 27%) furnished 49 mg of a mixture of isochavicol acetate,
n-butyrate, n-valerate and n-hexanoate from 33 mg of isochavicol (Figure
S1 of the Supporting Information).
Ester Mixture 2. The use of a mixture of propionyl, isobutyryl, and
2-methylbutyryl chlorides as acylating agents (respective massic percen-
tages of 25, 47, and 28%) furnished 24 mg of a mixture of isochavicol
propionate (3), isobutyrate (2), and 2-methylbutyrate (4) from 25 mg of
isochavicol (Figure S2 of the Supporting Information).
4-(Prop-(1E)-enyl)phenyl Isobutyrate (2) (64%). 1H NMR (Figure S3
of the Supporting Information) δ 1.31 [d, 6H, J = 7.0 Hz; (CH3)2CH], 1.87